Cargando…

Early- versus late-onset Alzheimer’s disease in clinical practice: cognitive and global outcomes over 3 years

BACKGROUND: Whether age at onset influences Alzheimer’s disease (AD) progression and the effectiveness of cholinesterase inhibitor (ChEI) therapy is not clear. We aimed to compare longitudinal cognitive and global outcomes in ChEI-treated patients with early-onset Alzheimer’s disease (EOAD) versus l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wattmo, Carina, Wallin, Åsa K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580278/ https://www.ncbi.nlm.nih.gov/pubmed/28859660 http://dx.doi.org/10.1186/s13195-017-0294-2

Ejemplares similares

Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression
por: Wattmo, Carina, et al.
Publicado: (2017)

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy
por: Wattmo, Carina, et al.
Publicado: (2016)

Predictors of long-term cognitive outcome in Alzheimer's disease
por: Wattmo, Carina, et al.
Publicado: (2011)

Galantamine treatment in Alzheimer’s disease: response and long-term outcome in a routine clinical setting
por: Wallin, Åsa K, et al.
Publicado: (2011)

Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer’s disease cohort
por: Wattmo, Carina, et al.
Publicado: (2012)

Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies
por: Wattmo, Carina, et al.
Publicado: (2013)

Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application
por: Wattmo, Carina, et al.
Publicado: (2013)

Solitary living in Alzheimer’s disease over 3 years: association between cognitive and functional impairment and community-based services
por: Wattmo, Carina, et al.
Publicado: (2014)

Similar pattern of atrophy in early- and late-onset Alzheimer's disease
por: Eckerström, Carl, et al.
Publicado: (2018)

A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2010)

Cerebral inflammation is an underlying mechanism of early death in Alzheimer’s disease: a 13-year cause-specific multivariate mortality study
por: Nägga, Katarina, et al.
Publicado: (2014)

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
por: Palmqvist, Sebastian, et al.
Publicado: (2012)

Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer’s disease
por: Kim, Jaeho, et al.
Publicado: (2021)

Response to cholinesterase inhibitors affects lifespan in Alzheimer’s disease
por: Wattmo, Carina, et al.
Publicado: (2014)

Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil
por: Persson, Cecilia M, et al.
Publicado: (2009)

Early and late-onset Alzheimer's disease: What are the differences?
por: Awada, Adnan A.
Publicado: (2015)

Neonatal Septicemia in Nepal: Early-Onset versus Late-Onset
por: Ansari, Shamshul, et al.
Publicado: (2015)

Short-Term Response to Cholinesterase Inhibitors in Alzheimer’s Disease Delays Time to Nursing Home Placement
por: Wattmo, Carina, et al.
Publicado: (2018)

Radiomic Features of the Hippocampus for Diagnosing Early-Onset and Late-Onset Alzheimer’s Disease
por: Du, Yang, et al.
Publicado: (2022)

Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
por: Mantyh, William G., et al.
Publicado: (2023)

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
por: Wattmo, Carina, et al.
Publicado: (2020)

SORL1 mutations in early- and late-onset Alzheimer disease
por: Cuccaro, Michael L., et al.
Publicado: (2016)

Early-Life Environment Influence on Late-Onset Alzheimer’s Disease
por: Gauvrit, Thibaut, et al.
Publicado: (2022)

Thalamic nuclei changes in early and late onset Alzheimer's disease
por: Forno, Gonzalo, et al.
Publicado: (2023)

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
por: Mukherjee, Shubhabrata, et al.
Publicado: (2018)

Glucose Metabolic Brain Networks in Early-Onset vs. Late-Onset Alzheimer's Disease
por: Chung, Jinyong, et al.
Publicado: (2016)

Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease
por: Lee, Wha Jin, et al.
Publicado: (2021)

Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease
por: Visser, Denise, et al.
Publicado: (2022)

Early‐onset Alzheimer's disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late‐onset
por: Tort‐Merino, Adrià, et al.
Publicado: (2022)

Psychopathological and temperamental features of Late Onset versus Early Onset Bipolar Disorder
por: Orsolini, L., et al.
Publicado: (2022)

Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer’s disease: a prospective, observational study of factors affecting survival time from admission to death
por: Wattmo, Carina, et al.
Publicado: (2016)

Differences between Early and Late-Onset Alzheimer’s Disease in Neuropsychological Tests
por: Sá, Francisca, et al.
Publicado: (2012)

Functional Connectivity of the Hippocampus in Early- and vs. Late-Onset Alzheimer's Disease
por: Park, Kee Hyung, et al.
Publicado: (2017)

The relationship of early- and late-onset Alzheimer’s disease genes with COVID-19
por: Sirin, Seda, et al.
Publicado: (2022)

A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapy
por: Wattmo, Carina, et al.
Publicado: (2013)

LATE ONSET SCHIZOPHRENIA VERSUS EARLY ONSET SCHIZOPHRENIA : A COMPARISON OF CLINICAL FEATURES
por: Kulhara, Parmanand, et al.
Publicado: (1999)

Prevalence of medical comorbidity in early onset versus late-onset depression in Vindhya region
por: Singh, Rajesh, et al.
Publicado: (2021)

Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer’s disease
por: Llibre-Guerra, Jorge J, et al.
Publicado: (2023)

Distinct Changes in Global Brain Synchronization in Early-Onset vs. Late-Onset Parkinson Disease
por: Wang, Tianyu, et al.
Publicado: (2020)

Distinct Patterns of Interhemispheric Connectivity in Patients With Early- and Late-Onset Alzheimer’s Disease
por: Li, Kai-Cheng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_321f3mvac41je934mlp5sm3l4m